2
Clinical Trials associated with SC-102 / Not yet recruitingPhase 1 Phase Ⅰ Study to Evaluate the Safety/Tolerability, Pharmacokinetics, and Efficacy of SC-102 in Subjects with Advanced or Metastatic Solid Tumors That Express EphA2
This study will evaluate the safety, PK profile, and anti-cancer efficacy of SC-102 in subjects with advanced solid tumors
/ Not yet recruitingPhase 1 评价注射用SC-102在晚期恶性实体肿瘤患者中的安全性、PK特征和有效性的一期临床研究
[Translation] A phase I clinical study to evaluate the safety, PK characteristics and efficacy of SC-102 for injection in patients with advanced malignant solid tumors
评价注射用SC-102治疗晚期恶性实体瘤患者的安全性、PK特征、免疫原性和有效性
[Translation] To evaluate the safety, PK characteristics, immunogenicity and efficacy of SC-102 for injection in patients with advanced malignant solid tumors
100 Clinical Results associated with SC-102
100 Translational Medicine associated with SC-102
100 Patents (Medical) associated with SC-102
100 Deals associated with SC-102